Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.75M Sell
4,837
-602
-11% -$206K 0.2% 60
2026
Q1
$1.91M Sell
5,439
-809
-13% -$288K 0.25% 55
2025
Q4
$2.05M Sell
6,248
-3,693
-37% -$1.17M 0.27% 54
2025
Q3
$2.81M Sell
9,941
-593
-6% -$172K 0.41% 41
2025
Q2
$2.94M Buy
10,534
+7,071
+204% +$2M 0.47% 36
2025
Q1
$1.08M Buy
3,463
+214
+7% +$63.2K 0.2% 65
2024
Q4
$847K Buy
3,249
+49
+2% +$14.5K 0.16% 68
2024
Q3
$1.03M Sell
3,200
-175
-5% -$57.2K 0.22% 61
2024
Q2
$1.05M Buy
3,375
+133
+4% +$39.1K 0.42% 48
2024
Q1
$922K Sell
3,242
-720
-18% -$211K 0.38% 54
2023
Q4
$1.14M Sell
3,962
-198
-5% -$53.9K 0.52% 36
2023
Q3
$1.12M Buy
4,160
+353
+9% +$88.1K 0.61% 36
2023
Q2
$845K Buy
3,807
+1,615
+74% +$375K 0.49% 40
2023
Q1
$551K Buy
2,192
+668
+44% +$164K 0.38% 42
2022
Q4
$400K Buy
+1,524
New +$409K 0.41% 46

Other funds holding AMGN

KFG Wealth Management's AMGN Position: Q2 2026 in Review

KFG Wealth Management reduced its Amgen (AMGN) stake by 11% in Q2 2026, selling an estimated $206K and leaving 4,837 shares worth $1.75M. The position accounts for 0.2% of the portfolio, ranked #60.

KFG Wealth Management first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.94M in Q2 2025. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • KFG Wealth Management held 4,837 shares of Amgen worth $1.75M as of Q2 2026.
  • KFG Wealth Management sold 602 Amgen shares in Q2 2026, an estimated $206K.
  • Amgen made up 0.2% of KFG Wealth Management's portfolio in Q2 2026, its #60 holding.
  • KFG Wealth Management first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • KFG Wealth Management's Amgen position peaked at $2.94M in Q2 2025.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on KFG Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.